{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,8]],"date-time":"2025-12-08T16:02:05Z","timestamp":1765209725839,"version":"3.46.0"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,12,8]],"date-time":"2025-12-08T00:00:00Z","timestamp":1765152000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,12,8]],"date-time":"2025-12-08T00:00:00Z","timestamp":1765152000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-27430-x","type":"journal-article","created":{"date-parts":[[2025,12,8]],"date-time":"2025-12-08T15:43:19Z","timestamp":1765208599000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Surgery versus chemoradiotherapy in patients with stage T1bN0M0 esophageal cancer: a retrospective cohort study"],"prefix":"10.1038","volume":"15","author":[{"given":"Zu-Yi","family":"Chen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shou-Feng","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Huan-Wei","family":"Liang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yang","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wei","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xin-Bin","family":"Pan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,12,8]]},"reference":[{"issue":"3","key":"27430_CR1","first-page":"209","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung, H. et al. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA Cancer J. Clin. 71(3), 209\u2013249 (2021).","journal-title":"CA Cancer J. Clin."},{"issue":"9","key":"27430_CR2","doi-asserted-by":"publisher","first-page":"1741","DOI":"10.1002\/ijc.34301","volume":"152","author":"H Zhu","year":"2023","unstructured":"Zhu, H. et al. Esophageal cancer in China: Practice and research in the new era. Int. J. Cancer. 152(9), 1741\u20131751 (2023).","journal-title":"Int. J. Cancer."},{"issue":"13","key":"27430_CR3","doi-asserted-by":"publisher","first-page":"8428","DOI":"10.1245\/s10434-021-10225-5","volume":"28","author":"Y Kanie","year":"2021","unstructured":"Kanie, Y. et al. Additional treatment following noncurative endoscopic resection for esophageal squamous cell carcinoma: A comparison of outcomes between esophagectomy and chemoradiotherapy. Ann. Surg. Oncol. 28(13), 8428\u20138435 (2021).","journal-title":"Ann. Surg. Oncol."},{"issue":"1","key":"27430_CR4","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s10388-018-0641-9","volume":"16","author":"Y Kitagawa","year":"2019","unstructured":"Kitagawa, Y. et al. Esophageal cancer practice guidelines 2017 edited by the Japan Esophageal Society: Part 1. Esophagus 16(1), 1\u201324 (2019).","journal-title":"Esophagus"},{"issue":"suppl 5","key":"27430_CR5","doi-asserted-by":"publisher","first-page":"v50","DOI":"10.1093\/annonc\/mdw329","volume":"27","author":"F Lordick","year":"2016","unstructured":"Lordick, F. et al. Oesophageal cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann. Oncol. 27(suppl 5), v50\u2013v57 (2016).","journal-title":"Ann. Oncol."},{"issue":"17","key":"27430_CR6","doi-asserted-by":"publisher","first-page":"1623","DOI":"10.1001\/jama.281.17.1623","volume":"281","author":"JS Cooper","year":"1999","unstructured":"Cooper, J. S. et al. Chemoradiotherapy of locally advanced esophageal cancer: Long-term follow-up of a prospective randomized trial (RTOG 85-01). Radiation Therapy Oncology Group. JAMA 281(17), 1623\u20131627 (1999).","journal-title":"JAMA"},{"issue":"6","key":"27430_CR7","doi-asserted-by":"publisher","first-page":"1878","DOI":"10.1053\/j.gastro.2021.08.007","volume":"161","author":"K Kato","year":"2021","unstructured":"Kato, K. et al. Parallel-group controlled trial of surgery versus chemoradiotherapy in patients with stage I esophageal squamous cell carcinoma. Gastroenterology. 161(6), 1878\u20131886 (2021).","journal-title":"Gastroenterology."},{"issue":"1","key":"27430_CR8","first-page":"doaa039","volume":"34","author":"M Fabbi","year":"2021","unstructured":"Fabbi, M., Hagens, E. R. C., van Berge Henegouwen, M. I. & Gisbertz, S. S. Anastomotic leakage after esophagectomy for esophageal cancer: definitions, diagnostics, and treatment. Dis. Esophagus. 34(1), doaa039 (2021).","journal-title":"Dis. Esophagus."},{"key":"27430_CR9","doi-asserted-by":"publisher","first-page":"17048","DOI":"10.1038\/nrdp.2017.48","volume":"3","author":"EC Smyth","year":"2017","unstructured":"Smyth, E. C. et al. Oesophageal cancer. Nat. Rev. Dis. Primers 3, 17048 (2017).","journal-title":"Nat. Rev. Dis. Primers"},{"issue":"13","key":"27430_CR10","doi-asserted-by":"publisher","first-page":"4765","DOI":"10.1245\/s10434-019-07779-w","volume":"26","author":"BJ Noordman","year":"2019","unstructured":"Noordman, B. J. et al. Quality of life during and after completion of neoadjuvant chemoradiotherapy for esophageal and junctional cancer. Ann. Surg. Oncol. 26(13), 4765\u20134772 (2019).","journal-title":"Ann. Surg. Oncol."},{"issue":"14","key":"27430_CR11","doi-asserted-by":"publisher","first-page":"1615","DOI":"10.1200\/JCO.2011.40.3568","volume":"30","author":"M Derogar","year":"2012","unstructured":"Derogar, M., Orsini, N., Sadr-Azodi, O. & Lagergren, P. Influence of major postoperative complications on health-related quality of life among long-term survivors of esophageal cancer surgery. J. Clin. Oncol. 30(14), 1615\u20131619 (2012).","journal-title":"J. Clin. Oncol."},{"issue":"7","key":"27430_CR12","doi-asserted-by":"publisher","first-page":"1677","DOI":"10.1007\/s11605-020-04817-x","volume":"25","author":"RE Merritt","year":"2021","unstructured":"Merritt, R. E., Abdel-Rasoul, M., Fitzgerald, M., D\u2019Souza, D. M. & Kneuertz, P. J. The academic facility is associated with higher utilization of esophagectomy and improved overall survival for esophageal carcinoma. J. Gastrointest. Surg. 25(7), 1677\u20131689 (2021).","journal-title":"J. Gastrointest. Surg."},{"issue":"1","key":"27430_CR13","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1177\/02184923231215539","volume":"32","author":"Z Muslim","year":"2024","unstructured":"Muslim, Z. et al. Impact of facility type and volume in locally advanced esophageal cancer. Asian Cardiovasc. Thorac. Ann. 32(1), 19\u201326 (2024).","journal-title":"Asian Cardiovasc. Thorac. Ann."},{"issue":"7","key":"27430_CR14","doi-asserted-by":"publisher","first-page":"1754","DOI":"10.1002\/cncr.26383","volume":"118","author":"MW Wouters","year":"2012","unstructured":"Wouters, M. W., Gooiker, G. A., van Sandick, J. W. & Tollenaar, R. A. The volume-outcome relation in the surgical treatment of esophageal cancer: A systematic review and meta-analysis. Cancer 118(7), 1754\u20131763 (2012).","journal-title":"Cancer"},{"issue":"5","key":"27430_CR15","doi-asserted-by":"publisher","first-page":"3021","DOI":"10.1097\/JS9.0000000000001185","volume":"110","author":"J Di","year":"2024","unstructured":"Di, J., Lu, X. S., Sun, M., Zhao, Z. M. & Zhang, C. D. Hospital volume-mortality association after esophagectomy for cancer: A systematic review and meta-analysis. Int. J. Surg. 110(5), 3021\u20133029 (2024).","journal-title":"Int. J. Surg."},{"issue":"18","key":"27430_CR16","doi-asserted-by":"publisher","first-page":"2487","DOI":"10.1111\/1759-7714.14096","volume":"12","author":"BR Kim","year":"2021","unstructured":"Kim, B. R. et al. The association between hospital case-volume and postoperative outcomes after esophageal cancer surgery: A population-based retrospective cohort study. Thorac. Cancer 12(18), 2487\u20132493 (2021).","journal-title":"Thorac. Cancer"},{"issue":"6","key":"27430_CR17","doi-asserted-by":"publisher","first-page":"608","DOI":"10.1093\/jjco\/hyt048","volume":"43","author":"K Kato","year":"2013","unstructured":"Kato, K. et al. Phase II study of concurrent chemoradiotherapy at the dose of 50.4 Gy with elective nodal irradiation for Stage II\u2013III esophageal carcinoma. Jpn. J. Clin. Oncol. 43(6), 608\u2013615 (2013).","journal-title":"Jpn. J. Clin. Oncol."},{"issue":"1","key":"27430_CR18","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.jtcvs.2008.05.016","volume":"137","author":"Y Tachimori","year":"2009","unstructured":"Tachimori, Y. et al. Salvage esophagectomy after high-dose chemoradiotherapy for esophageal squamous cell carcinoma. J. Thorac. Cardiovasc. Surg. 137(1), 49\u201354 (2009).","journal-title":"J. Thorac. Cardiovasc. Surg."},{"issue":"2","key":"27430_CR19","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1007\/s00268-009-0331-9","volume":"34","author":"H Takeuchi","year":"2010","unstructured":"Takeuchi, H. et al. Factors influencing the long-term survival in patients with esophageal cancer who underwent esophagectomy after chemoradiotherapy. World J. Surg. 34(2), 277\u2013284 (2010).","journal-title":"World J. Surg."},{"issue":"3","key":"27430_CR20","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1038\/modpathol.3800557","volume":"19","author":"T Eguchi","year":"2006","unstructured":"Eguchi, T. et al. Histopathological criteria for additional treatment after endoscopic mucosal resection for esophageal cancer: Analysis of 464 surgically resected cases. Mod. Pathol. 19(3), 475\u2013480 (2006).","journal-title":"Mod. Pathol."},{"issue":"4","key":"27430_CR21","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1111\/j.1440-1746.2007.05259.x","volume":"23","author":"DU Kim","year":"2008","unstructured":"Kim, D. U. et al. Risk factors of lymph node metastasis in T1 esophageal squamous cell carcinoma. J. Gastroenterol. Hepatol. 23(4), 619\u2013625 (2008).","journal-title":"J. Gastroenterol. Hepatol."},{"issue":"5","key":"27430_CR22","doi-asserted-by":"publisher","first-page":"897","DOI":"10.1007\/s10147-015-0819-2","volume":"20","author":"Y Murakami","year":"2015","unstructured":"Murakami, Y. et al. Long-term results of definitive concurrent chemoradiotherapy for patients with esophageal submucosal cancer (T1bN0M0). Int. J. Clin. Oncol. 20(5), 897\u2013904 (2015).","journal-title":"Int. J. Clin. Oncol."},{"issue":"10","key":"27430_CR23","doi-asserted-by":"publisher","first-page":"638","DOI":"10.1093\/jjco\/hyp069","volume":"39","author":"H Kato","year":"2009","unstructured":"Kato, H. et al. A phase II trial of chemoradiotherapy for stage I esophageal squamous cell carcinoma: Japan Clinical Oncology Group Study (JCOG9708). Jpn. J. Clin. Oncol. 39(10), 638\u2013643 (2009).","journal-title":"Jpn. J. Clin. Oncol."},{"issue":"14","key":"27430_CR24","doi-asserted-by":"publisher","first-page":"5025","DOI":"10.1002\/cam4.3132","volume":"9","author":"J Li","year":"2020","unstructured":"Li, J., Jia, Y., Cheng, Y. & Wang, J. Chemoradiotherapy vs radiotherapy for nonoperative early stage esophageal cancer: A seer data analysis. Cancer Med. 9(14), 5025\u20135034 (2020).","journal-title":"Cancer Med."},{"key":"27430_CR25","doi-asserted-by":"publisher","first-page":"2705","DOI":"10.1111\/jgh.70070","volume":"40","author":"RZ Wang","year":"2025","unstructured":"Wang, R. Z., Liang, H. W., Liu, Y., Huang, W. & Pan, X. B. Chemoradiotherapy versus radiotherapy in patients with stage T1N0M0 esophageal cancer: A retrospective cohort study. J. Gastroenterol. Hepatol. 40, 2705\u20132713 (2025).","journal-title":"J. Gastroenterol. Hepatol."},{"issue":"6","key":"27430_CR26","doi-asserted-by":"publisher","first-page":"1098","DOI":"10.1007\/s10147-020-01652-7","volume":"25","author":"Y Nakatani","year":"2020","unstructured":"Nakatani, Y. et al. Comparison of involved field radiotherapy and elective nodal irradiation in combination with concurrent chemotherapy for T1bN0M0 esophageal cancer. Int. J. Clin. Oncol. 25(6), 1098\u20131104 (2020).","journal-title":"Int. J. Clin. Oncol."},{"key":"27430_CR27","doi-asserted-by":"publisher","first-page":"857881","DOI":"10.3389\/fonc.2022.857881","volume":"12","author":"T Kawamoto","year":"2022","unstructured":"Kawamoto, T., Shikama, N., Mine, S. & Sasai, K. Comparison of recurrence patterns and salvage treatments after definitive radiotherapy for cT1a and cT1bN0M0 esophageal cancer. Front. Oncol. 12, 857881 (2022).","journal-title":"Front. Oncol."},{"issue":"1","key":"27430_CR28","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1093\/jjco\/hyad137","volume":"54","author":"K Sasaki","year":"2024","unstructured":"Sasaki, K. et al. A phase III randomized controlled trial comparing local field with additional prophylactic irradiation in chemoradiotherapy for clinical-T1bN0M0 esophageal cancer: ARMADILLO trial (JCOG1904). Jpn. J. Clin. Oncol. 54(1), 103\u2013107 (2024).","journal-title":"Jpn. J. Clin. Oncol."},{"issue":"3","key":"27430_CR29","doi-asserted-by":"publisher","first-page":"684","DOI":"10.1016\/j.ijrobp.2010.06.033","volume":"81","author":"K Kato","year":"2011","unstructured":"Kato, K. et al. Phase II study of chemoradiotherapy with 5-fluorouracil and cisplatin for Stage II-III esophageal squamous cell carcinoma: JCOG trial (JCOG 9906). Int. J. Radiat. Oncol. Biol. Phys. 81(3), 684\u2013690 (2011).","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"issue":"2","key":"27430_CR30","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1016\/j.radonc.2008.09.025","volume":"92","author":"M Onozawa","year":"2009","unstructured":"Onozawa, M. et al. Elective nodal irradiation (ENI) in definitive chemoradiotherapy (CRT) for squamous cell carcinoma of the thoracic esophagus. Radiother. Oncol. 92(2), 266\u2013269 (2009).","journal-title":"Radiother. Oncol."},{"issue":"7","key":"27430_CR31","doi-asserted-by":"publisher","first-page":"1175","DOI":"10.14309\/ajg.0000000000002106","volume":"118","author":"C Katada","year":"2023","unstructured":"Katada, C. et al. Curative management after endoscopic resection for esophageal squamous cell carcinoma invading muscularis mucosa or shallow submucosal layer-multicenter real-world survey in Japan. Am. J. Gastroenterol. 118(7), 1175\u20131183 (2023).","journal-title":"Am. J. Gastroenterol."},{"issue":"2","key":"27430_CR32","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1053\/j.gastro.2019.04.017","volume":"157","author":"K Minashi","year":"2019","unstructured":"Minashi, K. et al. Efficacy of endoscopic resection and selective chemoradiotherapy for stage I esophageal squamous cell carcinoma. Gastroenterology. 157(2), 382\u2013390 (2019).","journal-title":"Gastroenterology."},{"issue":"2","key":"27430_CR33","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1053\/j.gastro.2022.10.002","volume":"164","author":"K Nihei","year":"2023","unstructured":"Nihei, K. et al. Final analysis of diagnostic endoscopic resection followed by selective chemoradiotherapy for stage I esophageal cancer: JCOG0508. Gastroenterology 164(2), 296\u2013299 (2023).","journal-title":"Gastroenterology"},{"issue":"8","key":"27430_CR34","doi-asserted-by":"publisher","first-page":"1344","DOI":"10.14309\/ajg.0000000000002257","volume":"118","author":"X Yang","year":"2023","unstructured":"Yang, X. et al. Radiotherapy improves survival of patients with lymphovascular invasion in pT1b esophageal squamous cell cancer after endoscopic submucosal dissection. Am. J. Gastroenterol. 118(8), 1344\u20131352 (2023).","journal-title":"Am. J. Gastroenterol."},{"issue":"4","key":"27430_CR35","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1111\/den.13654","volume":"32","author":"R Ishihara","year":"2020","unstructured":"Ishihara, R. et al. Endoscopic submucosal dissection\/endoscopic mucosal resection guidelines for esophageal cancer. Dig. Endosc. 32(4), 452\u2013493 (2020).","journal-title":"Dig. Endosc."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-27430-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-27430-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-27430-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,8]],"date-time":"2025-12-08T15:43:20Z","timestamp":1765208600000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-27430-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,8]]},"references-count":35,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["27430"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-27430-x","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,8]]},"assertion":[{"value":"24 April 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 November 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"43364"}}